Zevia PBC (ZVIA) insiders plan to sell 40,000 shares via Merrill Lynch

Rhea-AI Filing Summary

Zevia PBC reports a proposed sale of 40,000 shares of Common Stock via Merrill Lynch, scheduled on 03/03/2026.

The filing notes those shares relate to a restricted stock unit award that vested on 01/17/2025.

Insights

Equity Compensation Analyst

Form 144 flags a standard post‑vesting sale of RSU shares by an insider or related holder.

The filing lists 40,000 common shares to be sold through Merrill Lynch with a trade date of 03/03/2026. The shares are tied to an RSU award that vested on 01/17/2025, indicating these are insider‑origin shares becoming eligible for sale.

Timing, pricing, and buyer details are not provided in the excerpt; subsequent transaction reports will show actual execution details and proceeds.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty Street Floor 37 New York NY 10281	40000	57514.00	67486641	03/03/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/17/2025	Vesting of restricted stock unit award	Zevia PBC			40000	01/17/2025	Granted as part of issuer equity compensation plan

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Zevia's Form 144 disclose about the shares to be sold?

It discloses a proposed sale of 40,000 common shares through Merrill Lynch with a trade date of 03/03/2026. The filing ties the shares to an RSU award that vested on 01/17/2025, showing the source of the shares.

Are the shares from a compensation award for ZVIA?

Yes. The filing states the shares relate to a restricted stock unit award that vested on 01/17/2025. That indicates the shares originated from the issuer's equity compensation plan.

Who is handling the sale of ZVIA shares reported in the filing?

The proposed sale is to be executed through Merrill Lynch, as listed in the filing. The document does not disclose the sale price or final execution details.

Will this Form 144 change Zevia's outstanding share count?

The Form 144 reports the proposed sale of 40,000 shares; it does not state any change to authorized or outstanding shares. Any change in beneficial ownership will appear in subsequent transactional filings.